相关实验视频

Updated: Jun 24, 2025

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

在有物质使用和双重疾病的患者中微清除C型肝炎 - - 一项葡萄牙研究

Isabela Faria¹, Rita Facão², Filipa Murta³

¹Psychiatry Department, Coimbra Hospital and University Center (CHUC), Portugal.

Japanese journal of infectious diseases

|June 2, 2024

概括

这项研究发现葡萄牙精神病患者中肝炎C病毒 (HCV) 感染的患病率较高. 早期检测和干预对于这个脆弱的人群至关重要.

科学领域:

肝病学肝病学是一种肝病学.
精神病学是一个精神病学.
传染性疾病传染性疾病

背景情况:

慢性肝炎C (CHC) 是一个重要的公共卫生问题.
肝炎C病毒 (HCV) 感染在患有精神疾病的人群中更为普遍.
之前没有研究研究葡萄牙患者的HCV患病率,这些患者同时患有精神病和物质使用障碍.

研究的目的:

确定在科因布拉医院和大学中心 (CHUC) 双病理科治疗的患者中HCV抗体和CHC的患病率.
描述与此患者队列中HCV感染相关的人口和风险因素.

主要方法:

进行了一项观察性,前性研究.
来自双重病理门诊和住院病房的149名患者进行了HCV抗体测试.
检测到HCVRNA,以确认活动的CHC.

主要成果:

17.4%的患者检测出HCV抗体呈阳性.
7.4%的人有可检测的HCVRNA,表明CHC.
确认的CHC病例主要是50-59岁的男性住院患者,有多个性伴侣,有药物使用障碍病史.

结论:

与葡萄牙普通人口相比,患有双重精神疾病和物质使用障碍的患者中,HCV抗体和CHC的患病率显著更高.
这凸显了在精神病学环境中针对HCV进行有针对性的查和综合治疗的必要性.
调查结果强调了解决这一群体中不保护性行为和物质使用等风险因素的重要性.

关键词:

型肝炎C型肝炎的发生在HCV抗体中.双重障碍是一种双重障碍.精神病学是一种精神病学.药物使用障碍物使用障碍物.

更多相关视频

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

相关概念视频

Drug Elimination: Non-Renal Routes

Drug Elimination: Non-Renal Routes

The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...

Hepatic Drug Excretion: Enterohepatic Cycling

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...